47. Richmond, R. S., Carlson, C. S., Register, T. C., Shanker, G. Loeser, R. F. Functional estrogen receptors in adult articular cartilage: Estrogen replacement therapy increases
chondrocyte synthesis of proteoglycans and insulin-like growth factor binding protein 2.
Arthritis Rheum.
43, 2081 –2090 2000.
48. Ushiyama, T., Ueyama, H., Inoue, K., Ohkubo, I. Hukuda, S. Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes.
Osteoarthr. Cartil. OARS Osteoarthr. Res. Soc.
7, 560 –566 1999.
49. Lee, Y. J.
et al.
Effect of estrogen on the expression of matrix metalloproteinase MMP-1, MMP-3, and MMP-13 and tissue inhibitor of metalloproternase-1 in osteoarthritis
chondrocytes.
Rheumatol. Int.
23, 282 –288 2003.
50. Richette, P.
et al.
Dual effects of 17ss-oestradiol on interleukin 1ss-induced proteoglycan degradation in chondrocytes.
Ann. Rheum. Dis.
63, 191 –199 2004.
51. Claassen, H., Schünke, M. Kurz, B. Estradiol protects cultured articular chondrocytes from oxygen-radical-induced damage.
Cell Tissue Res.
319, 439 –445 2005.
52. Dietrich, W.
et al.
Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia.
J. Soc. Gynecol. Investig.
13, 512 –517 2006.
53. Weitzmann, M. N. Pacifici, R. Estrogen deficiency and bone loss: an inflammatory tale.
J. Clin. Invest.
116, 1186 –1194 2006.
54. Cenci, S.
et al.
Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-?
J. Clin. Invest.
106, 1229 –1237 2000.
55. Demers, L. in
The textbook of clinical chemistry
WB Saunders Company, 1999. 56. Aron, D. Findling, J. in
Basic and Clinical Endocrinology
Prentice-Hall International Inc, 1997.
57. Riggs, B. L., Khosla, S. Melton, L. J., 3rd. Sex steroids and the construction and conservation of the adult skeleton.
Endocr. Rev.
23, 279 –302 2002.
58. Weitzmann, M. N. Pacifici, R. The role of T lymphocytes in bone metabolism.
Immunol. Rev.
208, 154 –168 2005.
59. Kousteni, S.
et al.
Nongenotropic, sex-nonspecific signaling through the estrogen or androgen receptors: dissociation from transcriptional activity.
Cell
104, 719 –730 2001.
60. Teitelbaum, S. L. Bone resorption by osteoclasts.
Science
289, 1504 –1508 2000.
61. Khosla, S. Minireview: the OPGRANKLRANK system.
Endocrinology
142, 5050 –5055
2001.
62. Kim, N.
et al.
Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis.
J. Exp. Med.
202, 589 –595 2005.
63. Lam, J.
et al.
TNF-? induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand.
J. Clin. Invest.
106, 1481 –1488 2000.
